Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today ...
Here, you’ll have the opportunity to share your findings with a global audience and discuss your ideas with experts from around the globe. In addition to presenting at DDW 2023, accepted abstracts ...
Abivax to Present Data on Obefazimod at Digestive Disease Week®Presentations Highlight Comprehensive Efficacy, Safety, and Patient-Reported ...
Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that its artificial intelligence platforms will be featured in ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its three posters at the ...
BRIDGEWATER, NJ / ACCESS Newswire / May 1, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative ...
Evoke Pharma, Inc. announced that an abstract comparing the incidence of tardive dyskinesia (TD) in patients undergoing continuous versus intermittent oral metoclopramide treatment has been accepted ...
A large-scale national surveillance study looked at past colorectal cancer death trends and projected accelerating rates among Millennials and younger adults, highlighting the need for rethinking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results